Companies / Nuvation Bio Inc.
Nuvation Bio Inc.
NYSE: NUVBCIK 1811063NEW YORK, NY
Insider flow · last 90 daysNet sells $379.2K
Financials · FY2025
Ownership
351.1M shares outstanding · as of Aug 3, 2026
Ownership
| Institutions | 61.90% | 217,340,484 |
| Public float | 38.10% | 133,782,749 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 13
View all →| Insider | % of shares | Shares |
|---|---|---|
Makunje MosesFormerSEE REMARKS | 0.02% | 68,137 |
Wentworth KerryFormerCHIEF REGULATORY OFFICER | 0.02% | 53,000 |
Blickenstaff Kim DDirector | — | — |
Cui XiangminFormerDirector | — | — |
Falberg Kathryn EDirector | — | — |
Hanley David C.FormerCHIEF TECHNICAL OPERATIONS | — | — |
Hattersley GaryCHIEF SCIENTIFIC OFFICER | — | — |
Hung DavidCEOPRESIDENT AND CEO · Director · 10% owner | — | — |
Liu DongfangFormerCHIEF MEDICAL OFFICER | — | — |
Markel StacyFormerCHIEF PEOPLE OFFICER | — | — |
Institutional holders 234
View all →| Holder | Value | % of shares |
|---|---|---|
| $460.77M | 14.65% | |
| $232.55M | 7.39% | |
| $156.94M | 7.87% | |
| $139.38M | 4.43% | |
| $72.41M | 2.30% | |
| $41.87M | 2.10% | |
| $34.13M | 1.08% | |
| $33.56M | 2.23% | |
| $28.34M | 0.90% | |
| $25.55M | 0.81% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common Stock | $28.50M | +3.2M +505.48% | 3,809,425 1.08% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $16.82M | +3.0M +12.00% | 27,630,837 7.87% of shares | medium |
| Q1 2026 as of | Abrams Capital Management, L.P. 13F manager | Trim | Common Stock | $-10.90M | -2.5M -66.67% | 1,270,504 0.36% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $8.59M | +1.5M +25.81% | 7,370,794 2.10% of shares | medium |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common Stock | $8.36M | +1.9M +264.71% | 2,684,089 0.76% of shares | medium |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Trim | Common Stock | $-4.85M | -1.1M -91.61% | 103,546 0.03% of shares | low |
| Q1 2024 as of | Barclays PLC 13F manager | Add | Common Stock | $4.07M | +1.1M +229.88% | 1,605,706 0.46% of shares | low |
| Q1 2026 as of | Silvercrest Asset Management Group LLC 13F manager | New | Common Stock | $3.11M | +724K | 724,383 0.21% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| NUVB | Common Stock | 67080N101 |